MIG
RXRX icon

McGuire Investment Group’s Recursion Pharmaceuticals RXRX Stock Holding History

McGuire Investment Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,500
Closed -$93.6K – 123
2025
Q2 		$93.6K Sell
18,500
-5,000
-21% -$24.6K 0.01% 112
2025
Q1 		$124K Hold
23,500
– – 0.02% 110
2024
Q4 		$159K Buy
+23,500
New +$158K 0.02% 108

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McGuire Investment Group's RXRX Position: Q3 2025 in Review

McGuire Investment Group sold out of Recursion Pharmaceuticals (RXRX) in Q3 2025, closing a stake of 18,500 shares — an estimated $93.6K sold.

McGuire Investment Group first reported a position in RXRX in Q4 2024 and held it in 3 quarters. The position peaked at $159K in Q4 2024. 322 funds tracked by Wall St. Rank hold RXRX as of Q3 2025.

  • McGuire Investment Group reported no remaining Recursion Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • McGuire Investment Group sold 18,500 Recursion Pharmaceuticals shares in Q3 2025, an estimated $93.6K.
  • McGuire Investment Group first reported a position in Recursion Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • McGuire Investment Group's Recursion Pharmaceuticals position peaked at $159K in Q4 2024.
  • 322 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2025.

Based on McGuire Investment Group's 13F filing for Q3 2025, filed 21 Oct 2025.